ArticleJACC. Case reports2026
Polymorphic Ventricular Tachycardia and Torsades in Methadone Therapy Captured by Loop Recorder.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMethadone is associated with QT prolongation and risk of torsades de pointes, particularly at higher doses, and management becomes challenging when the precipitating factor cannot be eliminated. CASE SUMMARY: A 56-year-old man on high-dose methadone with an implantable loop recorder experienced 3 episodes of polymorphic ventricular tachycardia and ventricular fibrillation, including a prolonged 94-second syncopal event. Device electrograms demonstrated pause-dependent initiation with short-long-short sequences and marked QT prolongation preceding arrhythmia onset. Despite limited follow-up, he ultimately agreed to wearable cardioverter-defibrillator therapy and subsequent implantable cardioverter-defibrillator (ICD) placement for secondary prevention. DISCUSSION: This case highlights methadone-associated malignant ventricular arrhythmias, the importance of continuous rhythm monitoring, and the role of ICD insertion when the offending agent cannot be safely withdrawn. TAKE-HOME MESSAGE: In high-risk patients with recurrent ventricular arrhythmias on methadone, individualized monitoring and ICD therapy may be warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.